How was the presentation of the RRS HA Long Lasting dermal implant

Skin Tech Pharma Group presented an innovative dermal implant with a filler and biorevitalizant effect, as well as a new patented CO-Delivery technology. In addition, the company uses an innovative technological approach called Unheating, which prevents the partial breakdown of newly formed cross-linked hyaluronic acid.

On April 24, an online presentation and live discussion by leading aesthetic medicine specialists took place. Evgenia Ranneva and Oksana Doroshenko spoke in detail about the research conducted and the drug development process. Focusing on the use of the drug for various purposes, specialists managed to create a truly revolutionary dermal implant.

An important point in the creation of RRS HA Long Lasting was the appearance of an economical product for performing the Full Face procedure with one syringe. The composition of the drug includes cross-linked hyaluronic acid, in the production of which a fairly new technology for obtaining raw materials was used, as well as a protective buffer from a set of amino acids, thanks to which the components of the drug do not react with each other, and also contains a completely new ingredient - osmolyte.

Unheating technology is a new technological process that prevents partial disintegration of newly formed cross-linked hyaluronic acid. CO-DELIVERY – gradual dosed release of active components. And when this release occurs, HA fragments, amino acids and osmolytes appear simultaneously, which have different effects on the skin.

Innovative composition, method of application, high plasticity (the drug is able to integrate into the skin), osmolyte in the composition - all this indicates that RRS HA Long Lasting belongs to the category of highly safe drugs and, of course, can satisfy any patient. And of course, the use of Unheating and CO-DELIVERY technologies. All this together makes the drug innovative.

RRS HA Long Lasting is intended for the correction of skin photodamage of varying degrees and, accordingly, such manifestations as elastosis, sagging skin, wrinkles, pigmentation, dehydration.

During the discussion, participants were able to ask the speakers exciting questions, as well as see a live demonstration of the drug RRS HA Long Lasting from Evgenia Glebova and Vladlena Averina.

You can watch the full video of the presentation and discussion: